Dotmatics Virtual Mini-Summit 2024
The Dotmatics Virtual Mini-Summit 2024 showcased the company's vision for revolutionizing R&D through modern solutions, featured a deep dive and live demo of the AI-enabled Dotmatics Luma platform with integrations to key scientific tools, and included a customer story highlighting the successful deployment and efficiency gains of Luma Lab Connect in pharmaceutical research.
Dotmatics Vision
Thomas Swalla, CEO at Dotmatics, shares how Dotmatics is revolutionizing R&D with modern solutions.
Walkthrough and Deep Dive of Luma
Kalim Saliba, Chief Product Officer at Dotmatics, shares how Dotmatics Luma transforms data into a foundation for AI-enabled multimodal research.
Example Workflows and Demo of Luma
Experience Dotmatics Luma in action as Phil Mounteney, Regional VP of Science & Technology at Dotmatics, gives a live demo of powerful new integrations that seamlessly connect Dotmatics Luma with GraphPad Prism, Geneious Biologics, SnapGene, OMIQ, and FCS Express, enabling rapid and reliable scientific results.
Customer Story: Deploying Luma Lab Connect
Matthew Kunicki, former scientist at a top pharmaceutical company and now CEO and Founder of CytIQ Inc., shares his hands-on experience with deploying Luma Lab Connect. Gain insights into the challenges he faced, the solutions he considered, and the significant benefits realized, including increased efficiency and valuable time savings for scientists.
Ready to transform to data-driven decision making?
Contact our team by emailing luma@dotmatics.com or request a personalized demo.
Related
The Data Lifecycle: From Instrument Integration to Advanced Analysis
The article discusses how Dotmatics Luma™, a comprehensive scientific data platform, addresses the challenges faced by R&D teams in managing and integrating diverse, multimodal scientific data from instruments and various sources to streamline the entire data lifecycle—from ingestion and processing to advanced analysis—thereby enabling faster, AI-ready insights that accelerate innovation and research outcomes.
Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery
Dotmatics has launched the Luma Antibody & Protein Engineering Solution, the first in its Luma Multimodal R&D Solutions series, which integrates the Dotmatics Luma Scientific Intelligence Platform with key tools like Geneious, GraphPad Prism, and others to streamline and unify antibody discovery and development—particularly for monoclonal and multispecific antibodies—while supporting a broad range of therapeutic modalities including CAR-T, siRNA, ADCs, CRISPR, and vaccines within a collaborative, multimodal research environment.
How Luma Lab Connect Automates Lab Data Acquisition Across 100+ Instruments
Dotmatics Luma Lab Connect, part of the Dotmatics Luma multimodal scientific R&D platform, automates and streamlines the acquisition, management, and preparation of complex, multimodal lab data from over 100 diverse instruments and sources, addressing challenges of data security, integrity, and usability to enhance research productivity and enable FAIR data practices within a unified, low-code SaaS environment.
Why Your ELN Data Is Stuck — and How to Fix It
The article explains that traditional ELN data often remains unusable because it is stored as static attachments, but Luma solves this by directly connecting instrument data to ELNs and presenting it as live, interactive dashboards that harmonize multi-vendor data in real time, enabling filtering, calculations, and full audit trails within the experiment notebook.
Announcing Dotmatics Luma: Our New Scientific Data Platform
Dotmatics announces Luma, a new scientific data platform designed to address the challenges of managing and integrating vast, varied, and isolated scientific data from multiple sources and instruments, enabling researchers to automate data handling and accelerate data-driven breakthroughs in R&D.
Luma Platform Overview
Luma is a versatile multimodal scientific intelligence platform that supports diverse scientific disciplines and techniques by enabling low-code app creation with configurable workflows, data integration, AI/ML capabilities, and secure governance, facilitating scientific discovery and R&D across fields such as drug discovery, materials science, and biotechnology through adaptive, API-driven infrastructure and tailored user experiences.